Listed

Tectonic Therapeutic, Inc.

TECXNasdaqCIK 1681087HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$24.2m, Q2 FY2026
Net income−$22.3m, Q2 FY2026
Tectonic Therapeutic, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m8.1Research and development, Q3 FY2023, three months to 2023-09-30$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure7.2Research and development, Q4 FY2023, three months to 2023-12-31$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure10.8Research and development, Q1 FY2024, three months to 2024-03-31$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure7.1Research and development, Q2 FY2024, three months to 2024-06-30$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure14.3Research and development, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure9.2Research and development, Q4 FY2024, three months to 2024-12-31$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure13.0Research and development, Q1 FY2025, three months to 2025-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure17.2Research and development, Q2 FY2025, three months to 2025-06-30$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure16.9Research and development, Q3 FY2025, three months to 2025-09-30$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure16.3Research and development, Q4 FY2025, three months to 2025-12-31$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure20.9Research and development, Q1 FY2026, three months to 2026-03-31$20.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure18.0Research and development, Q2 FY2026, three months to 2026-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Selling, general and administrative$mnot reportednot reportednot reported9.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$9.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure0.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125304. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(10.1)Operating income, Q3 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure(9.4)Operating income, Q4 FY2023, three months to 2023-12-31−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure(13.0)Operating income, Q1 FY2024, three months to 2024-03-31−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure(11.4)Operating income, Q2 FY2024, three months to 2024-06-30−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure(19.6)Operating income, Q3 FY2024, three months to 2024-09-30−$19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(14.0)Operating income, Q4 FY2024, three months to 2024-12-31−$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating income, Q1 FY2025, three months to 2025-03-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(22.3)Operating income, Q2 FY2025, three months to 2025-06-30−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(21.9)Operating income, Q3 FY2025, three months to 2025-09-30−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(21.5)Operating income, Q4 FY2025, three months to 2025-12-31−$21.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(27.3)Operating income, Q1 FY2026, three months to 2026-03-31−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(24.2)Operating income, Q2 FY2026, three months to 2026-06-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$36.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$34.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$31.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$25.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$20.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$17.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$14.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$12.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$6.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figurenot reported1.0Income tax, Q2 FY2025, three months to 2025-06-30$976.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure0.3Income tax, Q4 FY2025, three months to 2025-12-31$254.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.1Income tax, Q2 FY2026, three months to 2026-06-30$77.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Net income$m(10.1)Net income, Q3 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure(7.9)Net income, Q4 FY2023, three months to 2023-12-31−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Net income, Q1 FY2024, three months to 2024-03-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(12.7)Net income, Q2 FY2024, three months to 2024-06-30−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(17.7)Net income, Q3 FY2024, three months to 2024-09-30−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(12.4)Net income, Q4 FY2024, three months to 2024-12-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(15.9)Net income, Q1 FY2025, three months to 2025-03-31−$15.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(20.0)Net income, Q2 FY2025, three months to 2025-06-30−$20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(19.0)Net income, Q3 FY2025, three months to 2025-09-30−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure(19.2)Net income, Q4 FY2025, three months to 2025-12-31−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(25.2)Net income, Q1 FY2026, three months to 2026-03-31−$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(22.3)Net income, Q2 FY2026, three months to 2026-06-30−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Diluted EPS$ per share(7.62)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$7.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figurenot reported(10.97)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$10.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure(4.34)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$4.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure(1.20)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figurenot reported(0.93)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(1.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(1.02)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figurenot reported(1.34)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(1.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Basic EPS$ per share(7.62)Basic EPS, Q3 FY2023, three months to 2023-09-30−$7.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figurenot reported(10.97)Basic EPS, Q1 FY2024, three months to 2024-03-31−$10.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure(4.34)Basic EPS, Q2 FY2024, three months to 2024-06-30−$4.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure(1.20)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figurenot reported(0.93)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(1.07)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure(1.02)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figurenot reported(1.34)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(1.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure

Balance sheet

Cash and equivalents$227.1m, Q2 FY2026
Shareholders' equity$223.8m, Q2 FY2026
Tectonic Therapeutic, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.3Cash and equivalents, Q3 FY2023, at 2023-09-30$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure28.8Cash and equivalents, FY2023, at 2023-12-31$28.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0000950170-25-042648.Report this figure18.7Cash and equivalents, Q1 FY2024, at 2024-03-31$18.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure185Cash and equivalents, Q2 FY2024, at 2024-06-30$185.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure159Cash and equivalents, Q3 FY2024, at 2024-09-30$159.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure141Cash and equivalents, FY2024, at 2024-12-31$141.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure306Cash and equivalents, Q1 FY2025, at 2025-03-31$306.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure287Cash and equivalents, Q2 FY2025, at 2025-06-30$287.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure268Cash and equivalents, Q3 FY2025, at 2025-09-30$268.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure254Cash and equivalents, FY2025, at 2025-12-31$253.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure237Cash and equivalents, Q1 FY2026, at 2026-03-31$236.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure227Cash and equivalents, Q2 FY2026, at 2026-06-30$227.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Current assets$m109Current assets, Q3 FY2023, at 2023-09-30$109.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062131.Report this figure30.9Current assets, FY2023, at 2023-12-31$30.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042648.Report this figure91.8Current assets, Q1 FY2024, at 2024-03-31$91.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057091.Report this figure187Current assets, Q2 FY2024, at 2024-06-30$187.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure163Current assets, Q3 FY2024, at 2024-09-30$162.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure147Current assets, FY2024, at 2024-12-31$146.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure310Current assets, Q1 FY2025, at 2025-03-31$309.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure291Current assets, Q2 FY2025, at 2025-06-30$290.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure273Current assets, Q3 FY2025, at 2025-09-30$273.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure257Current assets, FY2025, at 2025-12-31$257.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure240Current assets, Q1 FY2026, at 2026-03-31$239.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure231Current assets, Q2 FY2026, at 2026-06-30$231.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Total assets$m111Total assets, Q3 FY2023, at 2023-09-30$110.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062131.Report this figure39.4Total assets, FY2023, at 2023-12-31$39.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0000950170-25-042648.Report this figure92.3Total assets, Q1 FY2024, at 2024-03-31$92.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-057091.Report this figure194Total assets, Q2 FY2024, at 2024-06-30$193.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure169Total assets, Q3 FY2024, at 2024-09-30$168.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure153Total assets, FY2024, at 2024-12-31$152.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure315Total assets, Q1 FY2025, at 2025-03-31$314.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure295Total assets, Q2 FY2025, at 2025-06-30$295.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure277Total assets, Q3 FY2025, at 2025-09-30$277.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure261Total assets, FY2025, at 2025-12-31$261.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure247Total assets, Q1 FY2026, at 2026-03-31$246.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure237Total assets, Q2 FY2026, at 2026-06-30$237.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Current liabilities$m7.6Current liabilities, Q3 FY2023, at 2023-09-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062131.Report this figure40.9Current liabilities, FY2023, at 2023-12-31$40.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042648.Report this figure3.5Current liabilities, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057091.Report this figure26.0Current liabilities, Q2 FY2024, at 2024-06-30$26.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure17.3Current liabilities, Q3 FY2024, at 2024-09-30$17.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure11.6Current liabilities, FY2024, at 2024-12-31$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure13.5Current liabilities, Q1 FY2025, at 2025-03-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure11.4Current liabilities, Q2 FY2025, at 2025-06-30$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure9.4Current liabilities, Q3 FY2025, at 2025-09-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure9.7Current liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure13.0Current liabilities, Q1 FY2026, at 2026-03-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure10.4Current liabilities, Q2 FY2026, at 2026-06-30$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Total liabilities$m7.7Total liabilities, Q3 FY2023, at 2023-09-30$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062131.Report this figure43.4Total liabilities, FY2023, at 2023-12-31$43.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0000950170-25-042648.Report this figure3.5Total liabilities, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-057091.Report this figure27.5Total liabilities, Q2 FY2024, at 2024-06-30$27.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure18.4Total liabilities, Q3 FY2024, at 2024-09-30$18.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure12.1Total liabilities, FY2024, at 2024-12-31$12.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure13.8Total liabilities, Q1 FY2025, at 2025-03-31$13.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure11.5Total liabilities, Q2 FY2025, at 2025-06-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure9.5Total liabilities, Q3 FY2025, at 2025-09-30$9.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure9.7Total liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure16.2Total liabilities, Q1 FY2026, at 2026-03-31$16.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure13.2Total liabilities, Q2 FY2026, at 2026-06-30$13.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(79.8)Shareholders' equity, Q3 FY2023, at 2023-09-30−$79.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure(84.6)Shareholders' equity, FY2023, at 2023-12-31−$84.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076793.Report this figure(99.6)Shareholders' equity, Q1 FY2024, at 2024-03-31−$99.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure166Shareholders' equity, Q2 FY2024, at 2024-06-30$166.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure150Shareholders' equity, Q3 FY2024, at 2024-09-30$150.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure141Shareholders' equity, FY2024, at 2024-12-31$140.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure301Shareholders' equity, Q1 FY2025, at 2025-03-31$301.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure284Shareholders' equity, Q2 FY2025, at 2025-06-30$283.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure268Shareholders' equity, Q3 FY2025, at 2025-09-30$267.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure251Shareholders' equity, FY2025, at 2025-12-31$251.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure230Shareholders' equity, Q1 FY2026, at 2026-03-31$230.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure224Shareholders' equity, Q2 FY2026, at 2026-06-30$223.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure

Cash flow

Operating cash flow−$21.5m, Q2 FY2026
Capital expenditure$79.0k, Q2 FY2026
Tectonic Therapeutic, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125304. Derived: 9-month figure less the 6-month figure.Report this figure(11.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure(13.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104974. Derived: 6-month figure less the 3-month figure.Report this figure(19.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$19.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269701. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(14.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338062. Derived: 6-month figure less the 3-month figure.Report this figure(17.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269701. Derived: 9-month figure less the 6-month figure.Report this figure(14.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure(21.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338062. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125304. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0000950170-25-042648. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure(0.0)Capital expenditure, Q2 FY2024, three months to 2024-06-30−$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104974. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$153.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269701. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338062. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$181.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269701. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076793. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$79.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338062. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)18.96m, Q2 FY2026
Tectonic Therapeutic, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares43.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3043,772,990 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062131.Report this figure44.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3144,037,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-057091.Report this figure1.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,228,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001193125-24-200609.Report this figure1.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,319,147 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125304.Report this figure1.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,387,303 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067037.Report this figure2.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-302,919,872 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104974.Report this figure14.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3014,729,018 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure17.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3117,157,661 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure18.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3018,680,042 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure18.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3018,712,767 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269701.Report this figure18.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3118,769,004 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212016.Report this figure19.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3018,964,008 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure

Shares outstanding: 19.55mShares outstanding, period not labelled, at 2026-07-3119,549,366 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338062.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.